- Low
- 123,240
- Average
- 123,240
- Median
- 123,240
- High
- 123,240
Mdrna Salary
37
65
14
Mdrna average salary is $123,240, median salary is $123,240 with a salary range from $123,240 to $123,240.
Mdrna salaries are collected from government agencies and companies. Each salary is associated with a real job position. Mdrna salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Mdrna salaries are collected from government agencies and companies. Each salary is associated with a real job position. Mdrna salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
| Job Title | Salaries | City | Year | More info |
Related Mdrna Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Mdrna salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Guyp Salary Mdrna Jobs
| See more Mdrna Jobs» | |
| Search All Jobs | |
Patents information
294
All Patents
53
Grant Patents
231
Patents Pending
102
Patents Families
More Recent
Mdrna... Information
- MDRNA , Inc.
- Industry: Other
- City: Bothell, WA
- MDRNA, Inc. (MDRNA) is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (RNAi). The Company¡¯s infrastructure provides for pre-clinical scale manufacturing of both siRNAs and delivery materials, the comprehensive analysis and optimization of these compounds both individually and as drug candidates, and the filing of Investigational New Drug Applications. The Company develops RNAi-based product candidates for the treatment of cancer, metabolic disorders, inflammation, and viral infections. It focuses on siRNA constructs, such as dicer substrates and three-stranded meroduplexes, and delivery systems for improved siRNA delivery. MDRNA¡¯s various development programs comprise: oncology; metabolic
